Fortrea (FTRE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Voting matters and shareholder proposals
Election of three directors: Anshul Thakral, Peter M. Neupert, and William J. Sharbaugh, with board recommending a vote for each.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory (non-binding) approval of named executive officer compensation.
Other business may be addressed as properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Executive compensation and say-on-pay
Shareholders are asked to approve, on an advisory basis, the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Fortrea
- Annual meeting covers director elections, auditor ratification, and executive pay, with strong governance focus.FTRE
Proxy filing27 Apr 2026 - Driving clinical trial modernization and margin expansion in a $40B global market.FTRE
44th Annual J.P. Morgan Healthcare Conference13 Apr 2026 - 2025 results met guidance; 2026 targets margin growth and stability despite goodwill impairment.FTRE
Q4 202526 Feb 2026 - Debt reduction, execution focus, and margin improvements drive confidence in 2024 guidance.FTRE
Fireside Chat3 Feb 2026 - Strong book-to-bill, commercial transformation, and debt reduction drive improved outlook.FTRE
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Q2 2024 saw revenue and earnings decline, but sequential EBITDA and cash flow improved as debt fell.FTRE
Q2 20241 Feb 2026 - Balanced growth, disciplined execution, and tech-driven innovation drive margin expansion.FTRE
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 revenue fell 5.4% but backlog hit $7.6B and book-to-bill reached 1.23x.FTRE
Q3 202415 Jan 2026 - Q3 2025 results show strong cash flow, cost savings, and raised FY2025 guidance in a $40B market.FTRE
Investor presentation13 Jan 2026